|
Volumn 123, Issue 2, 2005, Pages 258-259
|
Intravitreal triamcinolone acetonide for macular edema associated with diabetic retinopathy and venous occlusive disease: It's time for clinical trials
|
Author keywords
[No Author keywords available]
|
Indexed keywords
TRIAMCINOLONE ACETONIDE;
ARGON PLASMA COAGULATION;
CATARACT;
CILIARY DISK;
CLINICAL TRIAL;
DIABETIC RETINOPATHY;
DRUG BIOAVAILABILITY;
DRUG EFFICACY;
DRUG SAFETY;
ENDOPHTHALMITIS;
FOLLOW UP;
GLAUCOMA;
HUMAN;
HYPERTENSION;
OBESITY;
PRIORITY JOURNAL;
RETINA BLOOD VESSEL OCCLUSION;
RETINA MACULA EDEMA;
RETINA VEIN OCCLUSION;
SHORT SURVEY;
TREATMENT OUTCOME;
VISUAL ACUITY;
VISUAL IMPAIRMENT;
VITRECTOMY;
CLINICAL TRIALS;
DIABETIC RETINOPATHY;
GLUCOCORTICOIDS;
HUMANS;
MACULAR EDEMA, CYSTOID;
RETINAL VEIN OCCLUSION;
TRIAMCINOLONE ACETONIDE;
VITREOUS BODY;
|
EID: 13244256884
PISSN: 00039950
EISSN: None
Source Type: Journal
DOI: 10.1001/archopht.123.2.258 Document Type: Short Survey |
Times cited : (24)
|
References (9)
|